Physician profile
Nancy A Dantzler
NPI 1598779266
$1,483.48
in general payments reported to CMS, 2019-2025
18 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.77 · 2022: $367 · 2023: $325 · 2024: $395 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $444.61 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $268.87 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $137.03 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.14 | 2022-2025 | Jardiance |
| Glaxosmithkline, LLC. | $106.90 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $87.38 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $68.02 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $65.47 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $35.42 | 2024 | Auvelity |
| Sanofi Pasteur INC. | $21.75 | 2022 | |
| Insulet Corporation | $20.79 | 2023 | Omnipod |
| Kyowa Kirin, INC. | $20.63 | 2023 | Nourianz |
| Urogen Pharma, INC. | $18.86 | 2025 | |
| Merck Sharp & Dohme LLC | $17.44 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.07 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.14 | 2022 | |
| Lundbeck LLC | $15.69 | 2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $13.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Dantzler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.